News
National Co-production Week 2022 runs from 4 to 9 July and is back for a 7th year. We look to the future of co-production at Parkinson's UK.
Campaigners share their work and plan activities to improve Parkinson's care
News on changes to the healthcare professionals who can issue fit to work notes from 1 July 2022 in England, Scotland and Wales.
An app that links to Apple Watch technology has been granted FDA approval to help monitor some motor symptoms experienced by people with Parkinson's.
We're calling on the Parkinson's community to take part in 5 important clinical studies that are currently at risk of closure.
Biotech company, NRG Therapeutics, has today announced an Innovate UK award to continue its drug development project, supported by the Parkinson's Virtual Biotech, into life-changing new treatments.
Research led by Cambridge University and part funded by Parkinson's UK shows that a form of brain scan could help identify those at risk of specific Parkinson's symptoms.
A trial of a new miniaturised deep brain stimulation (DBS) device, being carried out at Southmead Hospital in Bristol, aims to make improvements to existing surgery.
A pioneering partnership between global biopharmaceutical company UCB, Parkinson's UK and the Parkinson's Foundation in the US is laying the foundations for people with Parkinson's to feed into the drug development pipeline.
A new partnership between Alex Echo, Hydrow and Parkinson's UK will raise awareness of Parkinson's and the benefits of physical activity.